Travoprost intracameral implant exchanged at Month 18

Drug identity checked against registry records

Also recorded as iDose TR

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Performance of the Travoprost Intraocular ImplantNCT06582732Glaukos CorporationPhase 2Completed2023-11-02Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.